U.S. Markets close in 4 hrs 23 mins

Royalty Pharma plc (RPRX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
41.65-0.47 (-1.12%)
As of 4:00PM EDT. Market open.
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 356.50
52 Week Low 334.80
50-Day Moving Average 345.67
200-Day Moving Average 344.61

Share Statistics

Avg Vol (3 month) 33.24M
Avg Vol (10 day) 31.74M
Shares Outstanding 5388.13M
Implied Shares Outstanding 6N/A
Float 286.86M
% Held by Insiders 117.50%
% Held by Institutions 160.87%
Shares Short (Mar 30, 2021) 418.14M
Short Ratio (Mar 30, 2021) 44.01
Short % of Float (Mar 30, 2021) 46.35%
Short % of Shares Outstanding (Mar 30, 2021) 42.99%
Shares Short (prior month Feb 25, 2021) 410.64M

Dividends & Splits

Forward Annual Dividend Rate 40.68
Forward Annual Dividend Yield 41.61%
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 422.73%
Dividend Date 3Mar 14, 2021
Ex-Dividend Date 4May 18, 2021
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Dec 30, 2020


Profit Margin 45.94%
Operating Margin (ttm)78.24%

Management Effectiveness

Return on Assets (ttm)7.29%
Return on Equity (ttm)21.23%

Income Statement

Revenue (ttm)2.12B
Revenue Per Share (ttm)5.65
Quarterly Revenue Growth (yoy)25.10%
Gross Profit (ttm)1.89B
Net Income Avi to Common (ttm)495.2M
Diluted EPS (ttm)N/A
Quarterly Earnings Growth (yoy)-88.00%

Balance Sheet

Total Cash (mrq)2.06B
Total Cash Per Share (mrq)5.31
Total Debt (mrq)5.82B
Total Debt/Equity (mrq)58.78
Current Ratio (mrq)8.76
Book Value Per Share (mrq)N/A

Cash Flow Statement

Operating Cash Flow (ttm)2.03B
Levered Free Cash Flow (ttm)-1.09B